Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05024838
Other study ID # 2020-01-004CC
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date July 2022

Study information

Verified date August 2021
Source Taipei Veterans General Hospital, Taiwan
Contact Hung-Wei Cheng, MD
Phone 886-2-28757549
Email hwc1127@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Spinal anesthesia is one of the most used techniques for surgery. Anesthesiologists usually check the block height (dermatome) of spinal anesthesia before surgery start. More than 20 factors have been postulated to alter spinal anesthetic block height. We would like to use machine learning to comprehensively consider various factors such as physiological parameters and different drug characteristics to establish a predictive model to evaluate the sensory blockade of spinal anesthesia.


Description:

This is an observational study of the retrospective collection of patient data. The investigators retrospectively collected the electronic medical record of patients receiving spinal anesthesia from July 1, 2018, to Dec 31, 2018. Anesthesia-related factors such as anesthesiologist's expertise, injection site, patient position, the dosage of local anesthetics, needle size, the direction of needle bevel, and basic demographic information of the patients were used for data analysis. Patients less than 18 years old were excluded from this study. Twenty percent of the dataset was used as a testing dataset, and the remaining were used for model training. The investigators will utilize four machine learning algorithms as XGBoost (Extreme Gradient Boosting), AdaBoost (Adaptive Boosting), Random Forest (RF), and support vector machine (SVM). Model performances were evaluated visually with a confusion matrix.


Recruitment information / eligibility

Status Recruiting
Enrollment 3000
Est. completion date July 2022
Est. primary completion date July 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients receiving spinal anesthesia from July 1, 2018, to Dec 31, 2018, with available electronic medical records. Exclusion Criteria: - Age <18 years

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Machine learning methods
This is an observational study of the retrospective collection of patient data. Anesthesia-related factors such as anesthesiologist's expertise, injection site, patient position, the dosage of local anesthetics, needle size, the direction of needle bevel, and basic demographic information of the patients were used for data analysis. Patients less than 18 years old were excluded from this study. Twenty percent of the dataset was used as a testing dataset, and the remaining were used for model training. The investigators will utilize four machine learning algorithms as XGBoost (Extreme Gradient Boosting), AdaBoost (Adaptive Boosting), Random Forest (RF), and support vector machine (SVM). Model performances were evaluated visually with a confusion matrix.

Locations

Country Name City State
Taiwan Department of Anesthesiology, Taipei Veterans General Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Veterans General Hospital, Taiwan

Country where clinical trial is conducted

Taiwan, 

References & Publications (6)

Fanning N, Arzola C, Balki M, Carvalho JC. Lumbar dural sac dimensions determined by ultrasound helps predict sensory block extent during combined spinal-epidural analgesia for labor. Reg Anesth Pain Med. 2012 May-Jun;37(3):283-8. doi: 10.1097/AAP.0b013e31824b30d2. — View Citation

Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg. 1985 Jul;64(7):715-30. Review. — View Citation

Heng Sia AT, Tan KH, Sng BL, Lim Y, Chan ES, Siddiqui FJ. Hyperbaric versus plain bupivacaine for spinal anesthesia for cesarean delivery. Anesth Analg. 2015 Jan;120(1):132-40. doi: 10.1213/ANE.0000000000000443. Review. — View Citation

Horstman DJ, Riley ET, Carvalho B. A randomized trial of maximum cephalad sensory blockade with single-shot spinal compared with combined spinal-epidural techniques for cesarean delivery. Anesth Analg. 2009 Jan;108(1):240-5. doi: 10.1213/ane.0b013e31818e0fa6. — View Citation

Kozanhan B, Bardak O, Sami Tutar M, Ozler S, Yildiz M, Solak I. The influence of Body Roundness Index on sensorial block level of spinal anaesthesia for elective caesarean section: an observational study. J Obstet Gynaecol. 2020 Aug;40(6):772-778. doi: 10.1080/01443615.2019.1647523. Epub 2019 Aug 30. — View Citation

Kuok CH, Huang CH, Tsai PS, Ko YP, Lee WS, Hsu YW, Hung FY. Preoperative measurement of maternal abdominal circumference relates the initial sensory block level of spinal anesthesia for cesarean section: An observational study. Taiwan J Obstet Gynecol. 2016 Dec;55(6):810-814. doi: 10.1016/j.tjog.2015.04.009. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sensory blockade height of spinal anesthesia The record of sensory blockade level was extracted from retrospective electronic medical records as the primary outcome.
The investigators would like to use machine learning methods to consider various factors such as physiological parameters of patients, different drug characteristics, and different anesthesia providers to establish a predictive model to evaluate the sensory blockade of spinal anesthesia.
From time of starting spinal anesthesia until the time of testing blockage height, assessed up to 10 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05358535 - Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial) Phase 3
Recruiting NCT03839784 - Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient
Completed NCT04399226 - Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation
Completed NCT05383417 - No Post Intubation Laryngeal Symptoms N/A
Completed NCT03276533 - Dexmedetomidine Combined With Lidocaine Infusion Affect Inflammation Cytokines N/A
Enrolling by invitation NCT02104908 - Study of Nerve Block Anesthesia for Surgery of Hip Fracture in the Elderly Phase 4
Recruiting NCT01329874 - Anesthetic Efficacy of Gow-Gates Versus Conventional Inferior Alveolar Nerve Block Techniques N/A
Completed NCT01651988 - Efficacy of Ketamine-Propofol for Short Surgical Procedures Phase 4
Recruiting NCT01898897 - Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions N/A
Recruiting NCT04435834 - Individual Cerebral Hemodynamic Oxygenation Relationships Phase 4
Not yet recruiting NCT02143362 - Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake up Phase 4
Completed NCT02429323 - Endotracheal Intubation With Sevoflurane in Surgical Pediatric Patients N/A
Completed NCT02136641 - Study of Comparison of the Effectiveness of Three Diagrams for Sedation in Spinal Anesthesia Phase 4
Not yet recruiting NCT05869578 - Registry of Anesthesia and Perioperative Medicine
Completed NCT03134677 - The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section Phase 4
Enrolling by invitation NCT02355093 - Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically Phase 4
Completed NCT03161275 - Measurement of the Cerebral Saturation for Assessment of Safety of Epidural Anaesthesia During Abdominal Surgery N/A
Recruiting NCT03237429 - The Relationship Between BCM, Arterial Stiffness and Hemodynamic Instability During Induction of General Anesthesia
Active, not recruiting NCT05610007 - Comparison of Hyperbaric Prilocaine 2% 50 Mg and Hyperbaric Bupivacaine 0.5% 12.5 Mg Against Spinal Anesthesia Recovery Time in Cystoscopy Procedure Phase 4
Completed NCT04906772 - Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients Phase 4